Cytomegalovirus viremia associated with death or retransplantation in pediatric lung-transplant recipients

Transplantation

Volumn 75, Issue 9, 2003, Pages 1538-1543

  Danziger Isakov, Lara A ^a,c   DelaMorena, Maite ^a   Hayashi, Robert J ^a   Sweet, Stuart ^a   Mendeloff, Eric ^a   Schootman, Mario ^b   Huddleston, Charles B ^a   DeBaun, Michael R ^a  

^a ST LOUIS CHILDREN S HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Campus Box 8116 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DACLIZUMAB; GANCICLOVIR; LYMPHOCYTE ANTIBODY; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; BRONCHIOLITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEATH; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEWBORN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROPHYLAXIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; GRAFT REJECTION; HUMANS; INFANT; INFANT, NEWBORN; LUNG TRANSPLANTATION; MALE; REOPERATION; TIME FACTORS; TISSUE DONORS; VIREMIA;

EID: 0037572210     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000061607.07985.BD     Document Type: Article

References (27)

1. Kramer MR, Marshall SE, Starnes VA, et al. Infectious complications in heart-lung transplant. Analysis of 200 episodes. Arch Intern Med 1993; 153: 2010.
2. Maurer JR, Tullis DE, Grossman RF, et al. Infectious complications following isolated lung transplant. Chest 1992; 101: 1056.
3. Kanj SS, Tapson V, Davis RD, et al. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997; 112(4): 924.
4. Ettinger NA, Bailey TC, Trulock EP, et al. Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group. Am Rev Respir Dis 1993; 147: 1017.
5. Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997; 86.
6. Duncan AJ, Dummer JS, Paradis IL, et al. Cytomegalovirus infection and survival in lung transplant recipients. J Heart Lung Transpl 1991; 10: 638.
7. Smyth RL, Scott JP, Higenbottam TW, et al. Experience of cytomegalovirus infection in heart-lung transplant recipients. Transpl Proc 1990; 22(4): 1820.
8. Duncan SR, Paradis IL, Yousem SA, et al. Sequelae of CMV pulmonary infections in lung allograft recipients. Am Rev Respir Dis 1992; 146: 1419.
9. Duncan SR, Paradis IL, Dauber JH, et al. Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients. Am Rev Respir Dis 1992. 146: 1213.
10. Duncan SR, Grgurich WF, Iacono AT, et al. A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation. Am J Respir Crit Care Med 1994; 150: 146.
11. Metras D, Viard L, Kreitmann B, et al. Lung infection in pediatric lung transplant: experience in 49 cases. Eur J Cardiothorac Surg 1999; 15: 490.
12. Schwartz GJ, Haycock GB, Edelmann CM Jr, et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259.
13. Schwartz GJ, Feld LG, Langford DJ. A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 1984; 104(6): 849.
14. Ljungman P, Griffiths P, Paya C. Definition of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094.
15. Yousem SA, Berry G, Brunt E, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. J Heart Transplant 1990; 9: 593.
16. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation of the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15: 1.
17. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of the nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12: 713.
18. Gerbase MW, Dubois D, Rothmeier C, et al. Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation. Chest 1999; 116(5): 1265.
19. Brennan DC, Garlock KA, Singer GG, et al. Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients. Transplantation 1997; 64(12): 1843.
20. Gane E, Saliba F, Valdecasas GJ, et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The oral Ganciclovir International Transplantation Study Group. Lancet 1997; 350: 1729.
21. Gutierrez CA, Chaparro C, Krajden M, et al. Cytomegalovirus viremia in lung transplant recipients receiving ganciclovir and immune globulin. Chest 1998; 113(4): 924.
22. Valantine HA, Luikart H, Doyle R, et al. Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone. Transplantation 2001; 72(10): 1647.
23. Kinane KA, Hillary IB. Quantitative and qualitative detection of cytomegalovirus-specific antibodies using two types of enzyme-linked immunosorbent assay. J Med Virol 1985; 16(4): 375.
24. Sererat MN, Schifano JV, Lau P, et al. Evaluation of cytomegalovirus (CMV) antibody screening for blood donors. Am J Clin Pathol 1986; 86(4): 523.
25. LeFor WM, Shires DL Jr, McGonigle AF, et al. Hemoconcentration prior to serology testing in hemodiluted cadaver bone and tissue donors. Clin Transplant 1995; 9(4): 297.
26. Bale JF Jr, Zimmerman B, Dawson JD, et al. Cytomegalovirus transmission in child care homes. Arch Pediatr Adolesc Med 1999; 153(1): 75.
27. Pass RF, Hutto C, Ricks R, et al. Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Eng J Med 1986; 314(22): 1414.